January 6, 2010 — Quality of life (QOL) is significantly improved for patients with chronic sinusitis who undergo endoscopic surgery, according to the results of a prospective, multi-institutional ...
People who’ve been suffering from allergies for a long time without relief might actually have chronic sinusitis, which requires a different treatment, a study has found. Hoping to help people get it ...
With a high recurrence rate following surgery to treat chronic sinusitis with nasal polyps, authors set out to investigate the effectiveness and safety of endoscopic sinus surgery (ESS) in a pediatric ...
ReOpen was the first ever large placebo-controlled clinical trial program to demonstrate statistically significant reduction of symptoms in chronic sinusitis patients without nasal polyps Clinical ...
ORLANDO, Fla. (Ivanhoe Newswire) - For an estimated 30 million American adults, the simple act of breathing can be a daily struggle. That’s one in eight adults across the U.S. battling the persistent ...
LOS ANGELES (KABC) -- Approximately 31 million Americans suffer from chronic sinusitis. When medications fail, seeking relief can often lead to surgery. Now there's a new device that can help ...
Researchers at the University of California San Diego and the Veterans Affairs San Diego Healthcare System have identified a ...
What if you'd been treated for years for a condition, only to find out that you'd long ago been misdiagnosed? That's what's happening to a sizable number of Americans who are taking allergy meds (to ...
Jan. 7, 2003 — Chronic sinusitis can be difficult to treat, especially after sinus operations. Results of a pilot study reported in the December issue of Otolaryngology, Head and Neck Surgery suggest ...
Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial led by University College London (UCL) along with academics at the University ...
SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...